Camlin Fine Sciences · NSE: CAMLINFINE · BSE: 532834
Q3 FY24 results · Oct–Dec 2023
Camlin Fine Sciences reported revenue from operations of ₹385.89 crore (down 0.5% from Q3 FY23) and net loss of ₹14.28 crore for Q3 FY24 (Oct–Dec 2023), on a consolidated basis.
| Item | Q3 FY24 | Q3 FY23 | YoY | Q2 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 385.89 | 387.84 | −0.5% | 405.88 | −4.9% |
| Other income | 1.66 | 9.76 | −83.0% | 1.76 | −5.5% |
| Total income | 387.55 | 397.60 | −2.5% | 407.64 | −4.9% |
| Profit before tax | (9.73) | 31.79 | Turned loss | (12.09) | Loss narrowed |
| Net profit for the period | (14.28) | 22.86 | Turned loss | (20.83) | Loss narrowed |
| Attributable to shareholders of the company | (11.79) | 24.04 | Turned loss | (19.38) | Loss narrowed |
| EPS, basic (₹) | (0.71) | 1.53 | Turned loss | (1.17) | Loss narrowed |
| Net margin (%) | -3.7 | 5.9 | -5.1 |
| Item | Q3 FY24 | Q3 FY23 | YoY | Q2 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 185.61 | 172.69 | +7.5% | 206.21 | −10.0% |
| Other income | 2.13 | 11.02 | −80.7% | 5.63 | −62.3% |
| Total income | 187.73 | 183.71 | +2.2% | 211.85 | −11.4% |
| Profit before tax | (17.69) | 19.34 | Turned loss | (0.52) | Loss widened |
| Net profit for the period | (11.64) | 15.79 | Turned loss | (1.46) | Loss widened |
| EPS, basic (₹) | (0.70) | 1.01 | Turned loss | (0.09) | Loss widened |
| Net margin (%) | -6.3 | 9.1 | -0.7 |
Consolidated
- Filed with BSE
- 10 Feb 2024, 11:58 IST
- Board meeting
- 09 Feb 2024
- Period
- 01 Oct 2023 to 31 Dec 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 10 Feb 2024, 11:58 IST
- Board meeting
- 09 Feb 2024
- Period
- 01 Oct 2023 to 31 Dec 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE